Fig. 1
From: Emerging molecular classifications and therapeutic implications for gastric cancer
Molecular classifications of gastric cancers (GCs): a the Asian Cancer Research Group (ACRG) classification; b the Cancer Genome Atlas (TCGA) classification. MSS microsatellite stable, TP53 tumor protein 53, MSI microsatellite instable, EMT epithelial-mesenchymal transition, MLH1 mutL homolog 1, CDH1 cadherin 1, EBV Epstein-Barr virus, CIN, chromosomal instability, GS genomically stable, RTK receptor tyrosine kinase, RAS resistance to audiogenic seizures, CDKN2A cyclin-dependent kinase inhibitor 2A, PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, ARID1A AT-rich interactive domain 1A, BCOR BCL6 corepressor, JAK2 janus kinase 2, PD-L programmed cell death ligand, CIMP CpG island methylator phenotype, RHOA ras homolog family member A, CLDN18 claudin 18, ARHGAP Rho GTPase-activating protein 6